Chronification and reversibility of migraine.

Trial Profile

Chronification and reversibility of migraine.

Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Migraine; Secondary headache disorders; Tension type headache
  • Focus Therapeutic Use
  • Acronyms CHARM
  • Most Recent Events

    • 13 Jul 2016 Status changed from recruiting to completed.
    • 21 Jul 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-005124-18).
    • 21 Jul 2012 Actual initiation date 12 Jul 2012 added as reported by EudraCT.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top